How pelvic inflammatory disease develops from untreated STIs: warning signs in adolescents and young women, fertility risks, and the importance of early treatment and partner management

Introduction

Pelvic inflammatory disease (PID) is an infectious and inflammatory syndrome of the female upper genital tract. It can involve the endometrium, fallopian tubes, ovaries, and adjacent pelvic structures. One of the most important pathways to PID is the ascending spread of untreated or inadequately treated sexually transmitted infections (STIs). In adolescents and young women, this is especially important because of the clinical burden of PID, the potential for delayed diagnosis, and the possible impact on future reproductive health [1].

PID does not always present with dramatic symptoms. Some patients have pelvic pain, abnormal bleeding, dyspareunia, fever, or abnormal vaginal discharge, while others have only mild or non-specific symptoms. That subtle presentation can delay recognition and treatment. The concern is that even clinically mild episodes may still be associated with tubal inflammation and later sequelae, which is why early clinical suspicion remains important [1],[8].

How untreated STIs can progress to PID

The basic mechanism is ascending infection from the lower genital tract to the upper genital tract. Among the most clinically important pathogens is Neisseria gonorrhoeae. A recent review on the management of urogenital gonococcal infection emphasizes the need for accurate diagnosis and appropriate treatment to reduce complications and ongoing transmission [2]. If infection persists, local inflammation can extend and contribute to the development of PID.

Although PID is classically linked to gonorrhoea and chlamydia, the risk of reproductive complications after Chlamydia trachomatis infection is not determined by a single factor. A 2026 cohort study found that prediction of reproductive complications integrates demographic, behavioural, host genetic, and infection-related factors, suggesting that individual risk is multifactorial and not easily predicted [8]. That does not lessen the importance of treatment; instead, it supports treating early because clinicians cannot reliably identify which patients will recover without sequelae and which may develop tubal damage [8].

Extragenital STIs also matter in transmission and reinfection pathways. A 2026 review on anorectal STIs describes biological and behavioural mechanisms that can sustain complex transmission networks. If these sites are not detected and managed, reinfection risk may persist, indirectly maintaining exposure to pathogens associated with PID [3].

Why adolescents and young women need special attention

The review focused on adolescent women and PID highlights the importance of this age group in both clinical care and prevention [1]. In real-world practice, adolescents and young women may present late, minimize symptoms, face barriers to care, or avoid seeking help because of stigma or confidentiality concerns. These factors can delay diagnosis of both STIs and PID [1].

In addition, the absence of high fever or severe pain does not rule out PID. Lower abdominal or pelvic pain, intermenstrual or postcoital bleeding, pain during sex, abnormal cervical or vaginal discharge, and pelvic tenderness should all raise concern for possible ascending infection, especially when there is a recent STI, a new sexual partner, or unprotected sexual exposure [1],[2].

Warning signs that should not be ignored

Important warning signs include:

• new lower abdominal or pelvic pain;
• pain during sexual intercourse;
• abnormal uterine bleeding, including intermenstrual or postcoital bleeding;
• abnormal vaginal discharge or cervicitis;
• fever, systemic malaise, or rapidly worsening pain;
• nausea, vomiting, or signs suggesting more severe illness;
• marked cervical motion tenderness or uterine/adnexal tenderness on examination.

These findings are not unique to PID, but when they occur in someone at risk for STIs they warrant prompt assessment, consideration of differential diagnoses, and early treatment when clinically indicated [1],[2].

Fertility risks and other long-term consequences

The significance of PID extends beyond the acute episode. Sequelae can include persistent pelvic pain, recurrent PID, ectopic pregnancy, and reduced fertility related to tubal injury [1],[8]. Recent evidence on Chlamydia trachomatis indicates that reproductive complications cannot be predicted simply from one clinical or demographic feature, which supports a cautious approach: treat promptly, prevent reinfection, and follow up when needed [8].

In practical terms, not every untreated STI progresses to PID, and not every episode of PID leads to infertility. However, cumulative risk of damage increases when infection persists, when there are repeated episodes, or when sexual partners are not evaluated and treated, allowing reinfection to occur [1],[2],[8].

Why early treatment matters

Early treatment aims to relieve symptoms, eradicate infection, and reduce both long-term complications and ongoing transmission. In urogenital gonorrhoea, up-to-date and appropriate management is essential for reducing complications and interrupting transmission chains [2]. Because PID is often polymicrobial and delayed treatment worsens prognosis, a reasonable clinical suspicion should prompt timely action according to current protocols, with clinical reassessment as needed [1],[2].

Health-system processes also matter. A standards-based, cloud-hosted clinical decision support system improved gonorrhoea treatment and HIV screening workflows, suggesting that such tools may help reduce missed opportunities and improve the quality of sexual and reproductive healthcare [6].

Partner management is part of treatment

Treating only the patient while leaving recent sexual partners untreated increases the chance of reinfection. For that reason, partner management is an essential part of evidence-based care. Identifying, evaluating, and treating recent sexual partners helps interrupt transmission, reduce recurrence, and improve the effectiveness of initial treatment [2],[3].

This is especially relevant when unrecognized extragenital infections may be present, because a partially treated transmission network can perpetuate risk [3]. Good care includes counselling, facilitating access to testing and treatment for partners, and clear advice to avoid sexual exposure that could lead to reinfection until the recommended management has been completed [2],[3].

Prevention and follow-up

Prevention depends on timely STI diagnosis, correct treatment, reassessment when symptoms persist, and strategies to reduce future exposure. In younger patients, care should be accessible, confidential, and non-stigmatizing to encourage early presentation [1]. When available, standardized clinical decision support may improve adherence to treatment and screening practices [6].

It is also important to explain that reproductive risk after chlamydia is heterogeneous and multifactorial [8]. Patients should be neither falsely reassured by mild symptoms nor led to assume that every infection causes the same outcome. The key message remains straightforward: diagnose early, treat properly, and prevent reinfection.

Conclusion

PID can develop from untreated STIs through ascending spread into the upper genital tract. In adolescents and young women, early recognition matters because symptoms may be subtle and reproductive consequences, while not inevitable, may be significant [1],[8]. Prompt treatment, appropriate management of gonorrhoea and other STIs, attention to extragenital infection sites, and treatment of sexual partners are central to reducing recurrence, transmission, and long-term harm [2],[3],[6].

References

[1] Authors. Adolescent women and pelvic inflammatory disease - Do we know their importance? Enfermedades infecciosas y microbiologia clinica (English ed.) (2026). https://pubmed.ncbi.nlm.nih.gov/42542345/ [2] Authors. Management of urogenital gonococcal infection. Drug and therapeutics bulletin (2026). https://pubmed.ncbi.nlm.nih.gov/42547312/ [3] Authors. Mechanisms, management and prevention of anorectal sexually transmitted infections. Nature reviews. Gastroenterology & hepatology (2026). https://pubmed.ncbi.nlm.nih.gov/42538441/ [4] Authors. Investing in enhanced HIV prevention among young men who have sex with men in Brazil: insights from fiscal health modeling. Journal of medical economics (2026). https://pubmed.ncbi.nlm.nih.gov/42543243/ [5] Authors. Sexual and gender minority youth experience serious mental health risks, yet are not impacted by typically efficacious interventions: secondary mental health outcomes from randomized controlled trial (ATN 149). Journal of child psychology and psychiatry, and allied disciplines (2026). https://pubmed.ncbi.nlm.nih.gov/42543151/ [6] Authors. A Standards-Based, Cloud-Hosted CDS System for Gonorrhea Treatment and HIV Screening. Learning health systems (2026). https://pubmed.ncbi.nlm.nih.gov/42534572/ [7] Authors. Magnitude and correlates of modern contraceptive non-use among women of reproductive age in Eswatini: a secondary analysis of data from a population-based cross-sectional survey. BMJ open (2026). https://pubmed.ncbi.nlm.nih.gov/42711073/ [8] Authors. Can we predict reproductive complications after Chlamydia trachomatis infection? A cohort study integrating demographic, behavioural, host genetic and infection-related factors. Sexually transmitted infections (2026). https://pubmed.ncbi.nlm.nih.gov/42711106/